Searched for
PIRAMAL DEMERGER
Vedanta demerger: What recent large demergers of Tata Motors, ITC and others tell us about possible listing timeline?Vedanta's mega demerger has created four new entities, with investors eagerly awaiting their stock market listings. Drawing parallels from ...- Vedanta demerger: Do you have the unlisted shares in your demat account? Here’s all you need to knowVedanta's recent demerger has resulted in four new unlisted companies added to shareholders' demat accounts. These entities are expected to...
- Vedanta demerger: When will the four new stocks list on NSE, BSE? Here's what investors can expectVedanta’s demerger has left investors awaiting the listing of its four newly carved-out entities, even as the parent stock continues to ris...
- Vedanta demerger: When will the four new stocks list on BSE, NSE? Here’s what recent demergers indicateMining giant Vedanta is set to demerge four businesses into separate listed entities, with May 1 as the record date. Shareholders will rece...
- Piramal Pharma gets locked in lower circuitThe Ajay Piramal entity’s listing follows the demerger from parent Piramal Enterprises (PEL) as part of an exercise to simplify its structu...
- Piramal Pharma lists share on BSE, NSEIn October 2021, the board of directors of PEL approved the demerger of the pharmaceuticals business and simplification of the corporate st...
- Piramal Pharma to debut on bourses on WednesdayLast Thursday, the company said it has received Sebi’s go-ahead to list its equity shares on domestic stock exchanges
- Piramal Enterprises trades ex-demerger; NBFC business lists at Rs 1,050The record date for the demerger of the pharma business from the finance business has been set as September 1 and stock traded ex-demerger ...
- Piramal shares to trade ex-demerger on TuesdayPiramal Enterprises has secured the approval of the National Company Law Tribunal (NCLT) for the demerger of its pharmaceutical business an...
- NCLT approves demerger of pharma business from Piramal EnterprisesAjay Piramal, chairperson of PEL said the company is on track to achieve the completion of demerger and separate listing of PPL by the thir...
- Piramal Enterprises Q2 results: Net profit drops by 32% due to DHFL costThe non-banking finance company incurred an exceptional cost of Rs 153 crore, which is primarily on account of DHFL. Without this, the net ...
- Piramal board okays demerger of pharma, financial services operationsThe amalgamation of PHL Fininvest Private Limited with PEL will create a listed non-banking financial services (NBFC) entity. The merged ho...
- Piramal Enterprise gets board nod for demerger and listing of pharma businessThe pharmaceuticals business will get vertically demerged from Piramal Enterprises and consolidated under Piramal Pharma Ltd (PPL), the gro...
- Piramal Enterprises board approves scheme for pharma biz demergerThe pharmaceuticals business will get demerged from Piramal Enterprises (PEL) and consolidated in Piramal Pharma, Piramal Enterprises said ...
- Piramal Enterprises cuts gains as company clears the airThe company made its stand clear through a communication to exchanges.
- Piramal Enterprises decides to demerge its healthcare and financial services businessesThe Piramal Group, which was primarily a pharmaceutical business, has diversified into areas such as finance, private and real estate fundi...
- Piramal Health hits 52-wk low, Piramal Life zoomsShares of Piramal Healthcare fell over 12 percent to hit 52-week low as investors gave a thumbs down to its planned financial services fora...
- Nicholas Piramal undecided on strategic partner in R&D coIn the process of demerging its research and development segment into a new company, pharma company Nicholas and Piramal will decide in the...
- Nicholas Piramal undecided on strategic partner in R&D companyPharma company Nicholas Piramal to decide on partner for its new entity to be demerged from itd R&D segment.
- NPIL to invest Rs 300 cr in R&D unit: Domestic pharma major Nicholas Piramal India (NPIL) has decided to invest some Rs 250-300 crore in the next two years in its recently dem...
Load More
